Proteasome subunit PSMD1 is a key therapeutic target in multiple myeloma

Journal:
Blood
Published:
DOI:
10.1182/blood.2025029358
Affiliations:
5
Authors:
19
Go to article
Institutions Authors Share
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
17.500000
17.500000
 0.92
VA Boston Healthcare System, United States of America (USA)
0.500000
 0.03
Xuzhou Medical University (XZMC), China
0.500000
 0.03
Jiangsu Provincial Key Laboratory of Critical Care Medicine, SEU, China
0.500000
 0.03
Interested in Biochemistry and Cell Biology?